Leadership team

Angus Russell
Graham Hetherington
Mike Cola
Sylvie Grégoire
Barbara Deptula
Anita Graham
Tatjana May
Joseph Rus
Sylvie Grégoire
Sylvie Grégoire
President, Human Genetic Therapies

Dr Grégoire has over 20 years of pharmaceutical and biotechnology experience. She most recently served as Executive Chairwoman of the Board of IDM Pharma, a biotechnology company in California. Prior to this she was CEO of GlycoFi, and has also held numerous leadership positions at Biogen Inc., in the United States and France. Dr Grégoire also worked for Merck & Co. in various positions in clinical research and in European regulatory affairs both in the US and abroad. Dr Grégoire received her Doctor of Pharmacy degree from the State University of New York at Buffalo, and her pharmacy degree from Université Laval, Québec City, Canada.